Technical Articles

CRBN Ligand
基于TR-FRET技术的CRBN配体筛选在蛋白质降解剂研发中的应用
Application of CRBN Ligand Screening Based on TR-FRET Technology in the Development of Protein Degraders
发布时间 2026-04-13
Thalidomide is a compound composed of glutarimide and phthalimide, and its derivatives lenalidomide and pomalidomide are collectively known as immunomodulatory imide drugs, primarily used to treat hematologic malignancies such as multiple myeloma.
View details
  • Drug Research
  • TR-FRET Technology
  • CRBN Ligand
  • Protein Degrader
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.